Oil-Dri of America (ODC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on December 11, 2024, with shareholders able to vote and ask questions online.
Key proposals include electing nine directors, ratifying Grant Thornton LLP as auditor, and amending the Certificate of Incorporation to increase authorized shares for a 2:1 stock split.
The company qualifies as a smaller reporting company and utilizes scaled SEC disclosure requirements.
Shareholders can vote online, by phone, or by mail, and may change their vote up to the meeting date.
Voting matters and shareholder proposals
Proposals: elect nine directors, ratify Grant Thornton LLP as auditor for fiscal 2025, approve amendment to increase authorized shares for a 2:1 stock split, and address other business as needed.
Board recommends voting FOR all proposals.
No shareholder proposals or nominations were received by the deadline.
Board of directors and corporate governance
Board consists of nine members, with a majority being independent.
Board committees include Audit, Compensation, Nominating, Retirement Plans, and Executive Committees.
The company is a "controlled company" under NYSE rules, relying on certain governance exemptions.
Board refreshment efforts include two new directors since 2021 and a focus on cybersecurity expertise.
Lead Director role is held by an independent director to enhance governance.
Latest events from Oil-Dri of America
- Q2 net sales hit $117.7M, EBITDA $22M, with resilience despite weather disruptions.ODC
Q2 202612 Mar 2026 - Record net income and Ultra Pet acquisition drive growth, with margin and sales gains.ODC
Q3 20241 Feb 2026 - Record sales, margin expansion, and Ultra Pet integration drive strong growth outlook.ODC
Q4 202419 Jan 2026 - Record sales, profit, and margin expansion driven by Ultra Pet and high-value segment growth.ODC
Q1 202511 Jan 2026 - Record FY2025 results with double-digit growth, strong cash flow, and a positive FY2026 outlook.ODC
Q4 20257 Jan 2026 - Record sales, margin expansion, and robust B2B and animal health growth in Q2.ODC
Q2 202526 Dec 2025 - Record results in 2025 and strong Q1 FY2026 earnings drive continued growth and investment.ODC
Q1 2026 & AGM 20259 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve stock split amid strong governance focus.ODC
Proxy Filing1 Dec 2025 - Virtual meeting to elect nine directors, ratify auditor, and highlight ESG and governance priorities.ODC
Proxy Filing1 Dec 2025